The RAS/RAF/MEK/ERK pathway is a critical signal transduction cascade that regulates cell division, differentiation, and survival, and is frequently implicated in cancer when dysregulated. Targeting this pathway with specific inhibitors is a promising therapeutic strategy in oncology, particularly for tumors with mutations in components like BRAF or KRAS.